CASP3 and colorectal carcinoma: To further verify the synergy and analyze the apoptotic impact exerted by the mimetics, a sub-lethal dose (1 μM) of each BH3 mimetic was administered alone or in combination in four CRC lines representative of each CMS and the percentage of cells with activated caspase-3 was measured by flow cytometry.